ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 143095 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 143095; 2) Community: the network communities that were significantly associated with the response to NSC 143095; 3) Molecule: the relationships between components within communities and NSC 143095; 4) MDR: the compounds that were significantly associated with the NSC 143095.

NSC Compound Enrichment Correlation
NSC 715775 11H-Indolo[1,2-b]indazolium, 11-[[4-(dimethylamino)phenyl]methylene]-6-methyl-, trifluoromethanesulfonate 0.0267520285931239 0.12007515
NSC 724628 4,11-bis[[2-(dimethylamino)ethyl]-amino]-1H-naphtho[2,3-f]in dole-5,10-dione 0.0267520285931239 0.66065837
NSC 733654 6-(3-Chloropropyl)-5,6-dihydro-9-methoxy-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 0.0267520285931239 0.53250837
NSC 760979 Null 0.0267520285931239 0.53611927
NSC 93134 HELLEBRIN 0.0267520285931239 0.27866305
NSC 95466 PCNU 0.0267520285931239 0.39119292
NSC 17551 1,3-Propanedione, 1-(3-pyridinyl)-3-(2,4,6-trimethyl- phenyl)- 0.0278435641331422 0.59296687
NSC 208734 ACLACINOMYCIN A 0.0278435641331422 0.56034293
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.0278435641331422 0.56495869
NSC 373355 Saframycin R 0.0278435641331422 0.088619866
Total:97  Current:63    [First] [Prev] [Next] [Last]